Ricerca

Pubblicazioni IRIS

• Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab
  Anno: 2025
• Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma
  Anno: 2025
• Assessing pathogenicity of germline ATM variation and mechanisms maintaining genomic integrity for response to therapy in a melanoma model
  Anno: 2025
• Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients
  Anno: 2024
• Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort
  Anno: 2024